Holen Sie sich die Stockscreener-App
7.14
1.71%
0.12
Schlusskurs vom Vortag:
$7.02
Offen:
$6.99
24-Stunden-Volumen:
192.30K
Relative Volume:
0.61
Marktkapitalisierung:
$161.81M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-7.5957
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
-1.92%
1M Leistung:
-24.52%
6M Leistung:
-2.99%
1J Leistung:
+68.79%
1-Tages-Spanne:
$6.94
$7.33
1-Wochen-Bereich:
$6.94
$7.595
52-Wochen-Spanne:
$2.76
$12.23
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.14 | 159.09M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
What New Catalysts Are Shaping the Narrative for Exagen? - Yahoo Finance
Comparing Fonar (NASDAQ:FONR) & Exagen (NASDAQ:XGN) - Defense World
Reviewing MacroGenics (NASDAQ:MGNX) & Exagen (NASDAQ:XGN) - Defense World
Will Exagen Inc. stock maintain dividend yield2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
Why Exagen Inc. (E08A) stock stays resilientWatch List & Daily Entry Point Trade Alerts - Newser
Is Exagen Inc. (E08A) stock good for wealth creationWeekly Trend Report & Daily Chart Pattern Signals - Newser
Is Exagen Inc. (E08A) stock protected from inflationTrade Volume Report & Free Technical Confirmation Trade Alerts - Newser
How Exagen Inc. (E08A) stock correlates with oil marketsQuarterly Profit Report & Expert Approved Momentum Trade Ideas - Newser
How higher bond yields impact Exagen Inc. (E08A) stockQuarterly Earnings Summary & Safe Entry Zone Identification - Newser
Is Exagen Inc. (E08A) stock supported by strong fundamentalsWeekly Trade Review & Verified Short-Term Plans - Newser
Exagen continues to execute on re-acceleration strategy, says Canaccord - TipRanks
Is Exagen Inc E08A a good long term investmentStock Market Trends & Free Realize Exceptional Returns - earlytimes.in
Exagen price target raised to $18 from $15 at B. Riley - MSN
What Wall Street predicts for Exagen Inc. stock price2025 Volatility Report & Low Risk Investment Opportunities - BỘ NỘI VỤ
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Yahoo Finance
Is Exagen Inc. (E08A) stock a momentum leaderMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Will Exagen Inc. stock split attract more investors2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Is Exagen Inc. stock a contrarian buyProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Exagen (XGN) Price Target Increased by 17.39% to 15.74 - MSN
Visual trend scoring systems applied to Exagen Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Entry Point & Fast Moving Market Watchlists - newser.com
Short interest data insights for Exagen Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How supply shortages influence Exagen Inc. (E08A) stock2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Can Exagen Inc. stock sustain revenue growth2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target By Investing.com - Investing.com South Africa
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target - Investing.com India
The Market Doesn't Like What It Sees From Exagen Inc.'s (NASDAQ:XGN) Revenues Yet As Shares Tumble 27% - simplywall.st
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):